be_ixf;ym_202105 d_18; ct_50

Select Page

The New Pfizers and Mercks of Health Care

The New Pfizers and Mercks of Health Care

“You should drink more water,” my friend told me.

It’s a running joke among my friends that I drink too little water. Most times, when we are rock climbing, they’ll drink several bottles of water before I’ve even taken a single sip.

Some people believe that drinking water is critical to health. And they’ll drink water all day, all the time.

For me, I drink water occasionally, usually when I’m thirsty … and that’s it.

That’s the way it’s been from the time I was a kid.

“Drink water all the time” is the kind of one-size-fits-all view of health that is often based on nothing more than belief, hearsay, junk science and companies’ marketing campaigns.

However, there’s a revolution brewing that is going to completely wipe out these kinds of one-size-fits-all health care beliefs.

Drink Less Water

This revolution is called precision medicine. At its simplest, precision medicine is the use of our genetic information, or genomes, in combination with our medical history.

Together, these two things are going to make diagnosing medical conditions more precise. That way, when you go to see the doctor, you don’t simply get some one-size-fits-all hokum like “drink more water” that may be true for some and false for many others.

Instead, a doctor will match your symptoms against a massive database that looks to precisely target what you have.

You will also be given a genetic diagnostic test that confirms this diagnosis. And finally, you’ll be prescribed a drug or treatment that precisely targets your individual symptoms.

No more one-size-fits-all health care. Now, medicine is going to be individual, personal and precise.

Health Care Giants

This revolution in precision medicine is going to completely and utterly upend the health care industry. Many of today’s big health care giants — companies such as Pfizer and Merck that many of you own because of their long track record of profitability and consistent dividends —are going to be destroyed. That’s because these companies built themselves on the back of the old version of health care … one that depends on the imprecision of “one size fits all” for their success.

Equally, there are numerous companies that have been developing their capability in precision medicine for a decade now. These companies are going to benefit from precision medicine and will completely dominate the field … becoming the new Pfizers and Mercks of health care.

Regards,

Paul Mampilly
Editor, Profits Unlimited

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I went all in with $310,000 and a year later, my portfolio was at $425,000. This I would have never accomplished with mutual funds, I will be following your research for the rest of my life thank you Paul and the team."

- Karl A.

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“I bought my first Of Paul’s stocks Nov. 1, 2017. I’m happy to say that I’m ahead $14,000. That’s more then 1/3 of what I invested with my money, and in 9 months. Thank you, Paul, you’re the real deal.”

- Larry

Share This